Retinal Migraine: from History to the Present Day
https://doi.org/10.18008/1816-5095-2024-4-643-649
Abstract
Retinal migraine is a rare migraine variant, initially described in 1882 as ‘ophthalmic megrim’. Since then, various terms have been used in the literature, such as “ocular migraine”, “monocular migraine”, and “migraine of the anterior visual pathway”. The lack of an unified definition led to controversy and potential confusion in defining the diagnosis. Later, the International Classification of Headache Disorders (ICHD-3) defined retinal migraine as repeated attacks of monocular visual disturbance, including scintillation, scotoma or blindness, associated with migraine headache, which are fully reversible. Retinal migraine should be considered a diagnosis of exclusion that requires ruling out other causes of transient monocular vision loss. The purpose of this review is to analyze the data on the prevalence, pathogenesis, clinical presentation, and differential diagnosis of retinal migraine reported in the literature.
About the Author
N. L. Sheremet
Krasnov Research Institute of Eye Diseases
Russian Federation
Russian Federation
Sheremet Natalia L., MD, Chief Researcher of the Retinal and Optic Nerve Pathology Department
Rossolimo str., 11A, B, Moscow, 119021
References
1. Pula JH, Kwan K, Yuen CA, Kattah JC. Update on the evaluation of transient vision loss. Clin Ophthalmol. 2016 Feb11;10:297–303. doi: 10.2147/OPTH.S94971.
2. Arnold M. Headache classification committee of the international headache society (ihs) the international classification of headache disorders. Cephalalgia. 2018;38:1– 211. doi: 10.1177/0333102417738202.
3. Hill DL, Daroff RB, Ducros A, Newman NJ, Biousse V. Most cases labeled as «retinal migraine» are not migraine. J Neuroophthalmol. 2007;27(1):3–8. doi: 10.1097/WNO.0b013e3180335222.
4. Evans RW, Daroff RB. Expert opinion: monocular visual aura with headache: retinal migraine? Headache. 2000 JulAug;40(7):603–604. doi: 10.1046/j.1526-4610.2000.00095.x.
5. Galezowski X. Ophthalmic megrim: An affection of the vasomotor nerves of the retina and retinal centre which may end in a thrombosis. 1. Lancet. 1882;119:176– 177. doi: 10.1016/S0140-6736(02)21503-2.
6. Fisher CM. Transient monocular blindness associated with hemiplegia. AMA Arch Ophthalmol. 1952 Feb;47(2):167–203. doi: 10.1001/archopht.1952.01700030174005.
7. Fisher CM. Cerebral ischemia—less familiar types. Clin Neurosurg 1971;18: 267–336.
8. Walsh FB, Hoyt WF. Vascular lesions and circulatory disorders of the nervous system. In: Walsh FB, Hoyt WF, eds. Clinical Neuroophthalmology, 3rd ed. Baltimore: Williams & Wilkins; 1969:1671–1689.
9. Carroll D. Retinal migraine. Headache. 1970 Apr;10(1):9–13. doi: 10.1111/j.1526-4610.1970.hed1001009.x.
10. Corbett JJ. Neuroophthalmic complications of migraine and cluster headaches. Neurol Clin. 1983 Nov;1(4):973–995.
11. Doyle E, Vote BJ, Casswell AG. Retinal migraine: caught in the act. Br J Ophthalmol. 2004 Feb;88(2):301–302. doi: 10.1136/bjo.2003.021808.
12. Pandit JC, Fritsche P. Permanent monocular blindness and ocular migraine. J R Soc Med. 1997 Dec;90(12):691–692. doi: 10.1177/014107689709001219.
13. Wolter JR, Burchfield WJ. Ocular migraine in a young man resulting in unilateral transient blindness and retinal edema. J Pediatr Opthalmol 1971;8:173–176. doi: 10.3928/0191-3913-19710801-09
14. Kline LB, Kelly CL. Ocular migraine in a patient with cluster headaches. Headache. 1980 Sep;20(5):253–257. doi: 10.1111/j.1526-4610.1980.hed2005253.x.
15. Hupp SL, Kline LB, Corbett JJ. Complicated migraine and vision. Headache Q. 1990;1:146–151.
16. Daroff RB. The eye and headache. Neuro Ophthalmol Jpn 2002;19:112–124.
17. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004;24(Suppl 1):1–160.
18. Chong YJ, Mollan SP, Logeswaran A, Sinclair AB, Wakerley BR. Current Perspective on Retinal Migraine. Vision (Basel). 2021 Aug 23;5(3):38. doi: 10.3390/vi-sion5030038.
19. Gan KD, Mouradian MS, Weis E, Lewis JR. Transient monocular visual loss and retinal migraine. CMAJ. 2005 Dec 6;173(12):1441–1442. doi: 10.1503/cmaj.050128.
20. Grosberg BM, Solomon S., Friedman DI, Lipton RB Retinal migraine reappraised. Cephalalgia Int. J. Headache. 2006; 26 :1275–1286. doi: 10.1111/j.1468-2982.2006.01206.x.
21. Maher ME, Kingston W. Retinal Migraine: Evaluation and Management. Curr Neurol Neurosci Rep. 2021 May 11;21(7):35. doi: 10.1007/s11910-021-01122-1. PMID: 33973068.
22. Karbozova KZ. Migraine: diagnosis and treatment (Literature review) Vestnik of the KyrgyzRussian Slavic University. 2022;22(5):55–61 (In Russ.). doi: 10.36979/1694-500X-2022-22-5-55-61.
23. Cutrer FM. Pathophysiology of migraine. Semin Neurol. 2006 Apr;26(2):171–180. doi: 10.1055/s-2006-939917. PMID: 16628527.
24. Sinclair AJ, Sturrock A, Davies B, Matharu M. Headache management: Pharmacological approaches. Pract. Neurol. 2015;15:411–423. doi: 10.1136/practneurol-2015-001167.
25. Filatova EG, Osipova VV, Tabeeva GR, Parfenov VA, Ekusheva EV, Azimova YE, Latysheva NV, Naprienko MV, SkorobogatykhKV, SergeevAV, Golovacheva VA, Lebedeva ER, ArtyomenkoAR, Kurushina OV, Koreshkina MI, AmelinAV, Akhmadeeva LR, Rachin AR, Isagulyan ED, Danilov AB, Gekht AB. Diagnosis and treatment of migraine: Russian experts’ recommendations. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):4–14 (In Russ.). doi: 10.14412/2074-2711-2020-4-4-14.
26. Amelin AV, Ignatov YuD, Skoromets AA, Sokolov AYu. Migraine (pathogenesis, clinical features, treatment)]. Moscow: MEDpress; 2011. 265 p. (In Russ.).
27. Tabeeva GR, Yakhno NN. Migraine. Moscow: GEOTARMedia; 2011. 622 p. (In Russ.).
28. Sergeev AV, Tabeeva GR, Azimova SE. Central neuronal hyperexcitability is a predisposition to migraine. Russian Journal of Pain. 2010;2(27):3–11 (In Russ.).
29. Winterkorn JMS. “Retinal Migraine” is an Oxymoron. J. Neuroophthalmol. 2007;27:1– 2. doi: 10.1097/WNO.0b013e3180334dd1.
30. Ota I, Kuroshima K, Nagaoka T. Fundus video of retinal migraine. JAMA Ophthalmol. 2013;131:1481–1482. doi: 10.1001/jamaophthalmol.2013.4686.
31. Budzinskaya MV, Shelankova AV, Mikhaylova MA, Plyukhova AA, Nuriyeva NM, Fomin AV. Analysis of changes in central macular thickness based on optical coherence tomography angiography findings in retinal vein occlusion. Annals of Ophthalmology 2016;132(5):15–22 (In Russ.). doi: 10.17116/oftalma2016132515-22.
32. Kaloshina AA, Sheremet NL. The importance of OCT angiography and Doppler ultrasound methods in diagnosis of optic neuropathies. Annals of Ophthalmology 2022;138(3):132–139 (In Russ.). doi: 10.17116/oftalma2022138031132.
33. Chaliha DR, Vaccarezza M, Charng J, Chen FK, Lim A, Drummond P, Takechi R, Lam V, Dhaliwal SS, Mamo JCL. Using optical coherence tomography and optical coherence tomography angiography to delineate neurovascular homeostasis in migraine: a review. Front Neurosci. 2024 Apr 15;18:1376282. doi: 10.3389/fnins.2024.1376282.
34. Liu Z, Jie C, Wang J, Hou X, Zhang W, Wang J, Deng Y, Li Y. Retina and microvascular alterations in migraine: a systemic review and metaanalysis. Front Neurol. 2023 Sep 28;14:1241778. doi: 10.3389/fneur.2023.1241778.
35. Kowacs PA, Maranhão Filho P, Piovesan EJ, Werneck LC. Leao’s cortical spreading depression: from experimental «artifact» to physiological principle. Neurology. 2005 Nov 8;65(9):1455–1459. doi: 10.1212/01.wnl.0000183281.12779.cd.
36. Bolay H, Moskowitz MA. The emerging importance of cortical spreading depression in migraine headache. Rev Neurol (Paris). 2005 Jul;161(6–7):655–657. doi: 10.1016/s0035-3787(05)85108-2.
37. Gouras P. Spreading depression of activity in amphibian retina. Am J Physiol. 1958 Oct;195(1):28–32. doi: 10.1152/ajplegacy.1958.195.1.28.
38. MartinsFerreira H, de Castro GO. Lightscattering changes accompanying spreading depression in isolated retina. J Neurophysiol. 1966 Jul;29(4):715–26. doi: 10.1152/jn.1966.29.4.715.
39. Wiedemann M, Lyhs B, Bartels JP, Sieber M. The pharmacological control of neuronal excitability in the retinal spreading depression model of migraine. Curr Med Chem. 2012;19(2):298–302. doi: 10.2174/092986712803414178.
40. Wang Y, Li Y, Wang M. Involvement of CGRP receptors in retinal spreading depression. Pharmacol. Rep. PR. 2016;68:935–938. doi: 10.1016/j.pharep.2016.05.001.
41. Mollan SP, Virdee JS, Bilton EJ, Thaller M, Krishan A, Sinclair AJ. Headache for ophthalmologists: Current advances in headache understanding and management. Eye. 2021;35:1574–1586. doi: 10.1038/s41433-021-01421-4.
42. Virdee J, Mollan SP. Photopsia. Pract. Neurol. 2020;20:415–419. doi: 10.1136/pract-neurol-2019-002460.
43. Azimova YE, Amelin AV, Alferova VV, Artemenko AR, Akhmadeeva LR, Golovacheva VA, Danilov AB, Ekusheva EV, Isagulyan ED, Koreshkina MI, Kurushina OV, Latysheva NV, Lebedeva ER, Naprienko MV, Osipova VV, Pavlov NA, Parfenov VA, Rachin AP, Sergeev AV, Skorobogatykh KV, Tabeeva GR, Filatova EG. Clinical guidelines «Migraine». S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(1-3):4-36 (In Russ.). doi: 10.17116/jnevro20221220134.
44. Lee SH, Shin JH, Hwang JW. Longlasting reversible monocular visual loss ofretinal migraine. Acta Neurol Belg. 2021 Dec;121(6):1877–1879. doi: 10.1007/s13760-020-01503-2.
45. Grosberg BM, Veronesi M. Retinal migraine. Handb Clin Neurol. 2024;199:381– 387. doi: 10.1016/B978-0-12-823357-3.00012-4.
46. Heath Jeffery RC, Chen FK, Lueck CJ. Blackout: Understanding transient vision loss. Aust J Gen Pract. 2021 Mar;50(3):136–140. doi: 10.31128/AJGP-03-20-5271.
47. Wong SH, Plant GT. How to interpret visual fields. Pract. Neurol. 2015;15:374–381. doi: 10.1136/practneurol-2015-001155.
48. Tezuka T, Shibata M, Hanaoka H, Izawa Y, Kikuchi T, Akino K, Ozawa Y, Saito M, Kaneko Y, Nakahara J, Takizawa T. Systemic lupus erythematosus mimicking retinal migraine: a case report. Cephalalgia. 2023 Dec;43(12):3331024231219477. doi: 10.1177/03331024231219477.
49. PengKP, ChenYT, FuhJL. Migraine andincidenceofischemic stroke: anationwidepopulationbased study. Cephalalgia 2017;37:327–335. doi: 10.1177/0333102416642602.
50. Chhabra N, Chiang CC, Di Nome MA, Houghton O, Carlin RE, O’Carroll CB, Dodick DW, Dumitrascu OM. Migrainous infarction of the eye: Two cases of monocular ischemic complications associated with retinal migraine. Cephalalgia. 2022 May;42(6):553–556. doi: 10.1177/03331024211056286.
51. Dumitrascu O, O’Carroll C, Houghton O, Acierno M. Ocular ischemic complications from retinal migraine. J Neurol Sci 2021;429:175. doi: 10.1016/j.jns.2021.118487.
52. El Youssef N, Maalouf N, Mourad A, Saade J, Khoury M. Teaching NeuroImages: Retinal migraine in action. Neurology. 2018;90:e992. doi: 10.1212/WNL.0000000000005130.
53. Solkin A, Gritsenko A. Retinal Migraine: Etiopathogenesis, Clinical Manifestations, Diagnosis, Treatment and Pharmacoprophylaxis. Neurology and Neurosurgery. Eastern Europe. 2023;13(2):258–267 (In Russ.). doi: 10.34883/PI.2023.13.2.045.
54. Sirbu CA, Nicolescu VM, Nitis AO. Retinal migraine, a contentious clinical entity. Rom J Mil Med. 2022;125(4):571–576. doi: 10.55453/rjmm.2022.125.4.5.
Review
For citations:
Sheremet N.L. Retinal Migraine: from History to the Present Day. Ophthalmology in Russia. 2024;21(4):643-649. (In Russ.) https://doi.org/10.18008/1816-5095-2024-4-643-649
Views:
617
Email this article 